GBM64 GBM Model
GBM64, a Patient-Derived Xenograft (PDX) model, is designed for brain cancer research. Use this model to explore the disease’s complexity and develop novel therapeutic strategies. PDX models like GBM64 bridge the gap between laboratory research and clinical trials. Researchers can leverage GBM64 to test potential drug candidates in an environment that closely resembles the human disease, increasing the chances of success in subsequent phases of drug development. GBM64 contributes to accelerated drug discovery and improved outcomes for brain cancer patients.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM64
Mouse Strain: Nu/Nu
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GBM64 Survival
Survival of orthotopic intracranial implanted GBM64 in Nu/Nu mice (n=5)
